Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Charron

Showing results (81-90 of 203) with videos related to

Pageof 21
Sort By:
La Revue De Medecine Interne|August 14, 2025
[Fabry disease during the last 20 years: Analysis of a cohort of 107 patients, and focus on the F113L variant]Olivier Lidove, Benjamin Subran, Camille Montardi, et al.
La Revue De Medecine Interne|November 18, 2025
[Erratum to "Fabry disease during the last 20 years: Analysis of a cohort of 107 patients, and focus on the F113L variant" [Rev Med Interne 46 (2025) 571-574]]Olivier Lidove, Benjamin Subran, Camille Montardi, et al.
Heart Rhythm|July 30, 2011
Contraction delay of the RV outflow tract in patients with Brugada syndrome is dependent on the spontaneous ST-segment elevation patternFrançois Rouzet, Vincent Algalarrondo, Samuel Burg, et al.
Heart (British Cardiac Society)|November 11, 2010
Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS studyAlbert A Hagège, Eric Caudron, Thibaud Damy, et al.
European Heart Journal|April 30, 2005
Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathyJean F Forissier, Philippe Charron, Sophie Tezenas du Montcel, et al.
Open Heart|February 17, 2025
Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of CardiologyKatarzyna Mizia-Stec, Juan R Gimeno, Philippe Charron, et al.
Heart (British Cardiac Society)|June 23, 2026
Cardiac and extracardiac outcomes after heart transplantation in laminopathiesGauthier Giordano, Guillaume Coutance, Karim Wahbi, et al.
Oncogene|February 10, 2021
Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAKXiao Xiang, Stéphanie Langlois, Marie-Eve St-Pierre, et al.
Heart Rhythm|May 16, 2026
Sudden cardiac death and major arrhythmic events in patients with Fabry disease: risk stratification in the FHFc multicenter studyYassine Temmar, Julie Proukhnitzky, Nicolas Lamblin, et al.
Clinical Genetics|February 15, 2024
Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathyFlavie Ader, Guillaume Jedraszak, Alexandre Janin, et al.
Pageof 21

Showing results (81-90 of 203) with videos related to

Sort By:
Pageof 21
La Revue De Medecine Interne|August 14, 2025
[Fabry disease during the last 20 years: Analysis of a cohort of 107 patients, and focus on the F113L variant]Olivier Lidove, Benjamin Subran, Camille Montardi, et al.
La Revue De Medecine Interne|November 18, 2025
[Erratum to "Fabry disease during the last 20 years: Analysis of a cohort of 107 patients, and focus on the F113L variant" [Rev Med Interne 46 (2025) 571-574]]Olivier Lidove, Benjamin Subran, Camille Montardi, et al.
Heart Rhythm|July 30, 2011
Contraction delay of the RV outflow tract in patients with Brugada syndrome is dependent on the spontaneous ST-segment elevation patternFrançois Rouzet, Vincent Algalarrondo, Samuel Burg, et al.
Heart (British Cardiac Society)|November 11, 2010
Screening patients with hypertrophic cardiomyopathy for Fabry disease using a filter-paper test: the FOCUS studyAlbert A Hagège, Eric Caudron, Thibaud Damy, et al.
European Heart Journal|April 30, 2005
Diagnostic accuracy of a 2D left ventricle hypertrophy score for familial hypertrophic cardiomyopathyJean F Forissier, Philippe Charron, Sophie Tezenas du Montcel, et al.
Open Heart|February 17, 2025
Hypertrophic cardiomyopathy and atrial fibrillation: the Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of CardiologyKatarzyna Mizia-Stec, Juan R Gimeno, Philippe Charron, et al.
Heart (British Cardiac Society)|June 23, 2026
Cardiac and extracardiac outcomes after heart transplantation in laminopathiesGauthier Giordano, Guillaume Coutance, Karim Wahbi, et al.
Oncogene|February 10, 2021
Identification of pannexin 1-regulated genes, interactome, and pathways in rhabdomyosarcoma and its tumor inhibitory interaction with AHNAKXiao Xiang, Stéphanie Langlois, Marie-Eve St-Pierre, et al.
Heart Rhythm|May 16, 2026
Sudden cardiac death and major arrhythmic events in patients with Fabry disease: risk stratification in the FHFc multicenter studyYassine Temmar, Julie Proukhnitzky, Nicolas Lamblin, et al.
Clinical Genetics|February 15, 2024
Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathyFlavie Ader, Guillaume Jedraszak, Alexandre Janin, et al.
Pageof 21